Evidence map›Paper›PMID 10763822›Full record

ArticleOncogene2000

Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival.

B A Johnson, M Geha, T K Blackwell

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. RNA-Binding Proteins in Acute Leukemias.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The role of tristetraprolin in cancer and inflammation.Frontiers in bioscience (Landmark edition) · 2012
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

B A JohnsonCenter for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
M Geha
T K Blackwell
Harvard University · US

Funding

THE STRUCTURE OF CLASS III MHC ANTIGENSP01HD017461 · NICHD · IMMUNE DISEASE INSTITUTE, INC. · PI ROSEN, FRED S. · 1985 to 1998
–
NICHD NIH HHS P01 HD17461
6 · The paper itself

Abstract

The immediate early protein tristetraprolin (TTP) is required to prevent inappropriate production of the cytokine TNF-alpha, and is a member of a zinc finger protein family that is associated with RNA binding. TTP expression is induced by TNF-alpha, and evidence indicates that TTP can bind and destabilize the TNF-alpha mRNA. TTP and the closely related TIS11b and TIS11d proteins are evolutionarily conserved, however, and induced transiently in various cell types by numerous diverse stimuli, suggesting that they have additional functions. Supporting this idea, continuous expression of each TTP/TIS11 protein at physiological levels causes apoptotic cell death. By various criteria, this cell death appears analogous to apoptosis induced by certain oncoproteins. It is also dependent upon the zinc fingers, suggesting that it involves action on appropriate cellular targets. TTP but not TIS11b or TIS11d also sensitizes cells to induction of apoptosis by TNF-alpha. The data suggest that the TTP and TIS11 immediate early proteins have similar but distinct effects on growth or survival pathways, and that TTP might influence TNF-alpha regulation at multiple levels.

Indexed as

DNA-Binding Proteins3T3 CellsAnimalsApoptosisCell LineCell SurvivalDNA, ComplementaryFeedbackGene Expression RegulationHeLa CellsHumansImmediate-Early ProteinsMiceOncogenesProteinsRecombinant Fusion ProteinsDNA-Binding ProteinsDNA, ComplementaryImmediate-Early ProteinsProteinsRecombinant Fusion ProteinsRNA, MessengerTristetraprolinTumor Necrosis Factor-alphaZFP36 protein, humanZfp36 protein, mouse

Identifiers

PMID10763822
OpenAlexW2318133697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.